Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in PCOS
NCT05802212Completed
- Sponsor
- Peking University Third Hospital
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS), sponsored by Peking University Third Hospital. Primary endpoints: Luteinizing hormone in serum at 12 weeks and 4-Androstenedione in serum at 12 weeks. Started Jun 2020; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05802212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05802212.